#4710
Expert Nurse
Virginia Seery

Mollie, I agree with your concern about recurrence and rapid disease progression after use of BRAF targeted therapies in the adjuvant setting (which we have not starting doing yet). It will be interesting to see if this pattern emerges from the data as it matures. And the side effects can be quite debilitating for some patients.